Department of ECE, Maria College of Engineering & Technology, Attoor, India.
Department of ECE, St. Xavier's Catholic College of Engineering, Chunkankadai, India.
Int J Numer Method Biomed Eng. 2020 Aug;36(8):e3371. doi: 10.1002/cnm.3371. Epub 2020 Jun 22.
This study proposes Grasshopper Optimization Algorithm (GOA) based type 1 diabetes mellitus system utilizing the nonlinear Bergman minimal model with proportional integral derivative (PID) controller. GOA is the optimization algorithm, which is utilized for selecting the optimized tuning parameters of the PID controller also solves the nonlinear system parameter identification problem. The novelty of the proposed study is to stabilize the glucose level in blood for type 1 diabetic patients by infusion of insulin in reduced time with optimal quantity. Without any intervention to the normal activities of patients, the supply of insulin injection and glucose monitoring is performed automatically for type 1 diabetic patients using this controller. In between the measured variable and set point, the difference is calculated by the PID controller to evaluate an error values. In realistic patient oriented conditions, the control performance evaluation, control optimization, and advanced patient modelling should be highly concentrated during the research/analysis on blood glucose control. Evaluation is performed to analyze control performances and implementation is done on Simulink/MATLAB environment. The performance analysis of the type 1 diabetes mellitus system with GOA technique is also discussed and to improve the control performance, to optimize the controller parameters. The simulation results have proved the substantial improvement in the performance of proposed algorithm with the better results achieved than the other conventional controllers such as PSO-PID and EHO-PID.
本研究提出了基于 Grasshopper Optimization Algorithm (GOA) 的 1 型糖尿病系统,利用非线性 Bergman 最小模型和比例积分微分 (PID) 控制器。GOA 是一种优化算法,用于选择 PID 控制器的优化整定参数,并解决非线性系统参数辨识问题。本研究的新颖之处在于通过以最佳剂量输注胰岛素来稳定 1 型糖尿病患者的血糖水平,从而减少所需时间。该控制器可以为 1 型糖尿病患者自动进行胰岛素注射和血糖监测,而无需对患者的正常活动进行任何干预。在 PID 控制器中,通过测量变量和设定点之间的差异来计算评估误差值。在现实的面向患者的条件下,血糖控制的研究/分析应高度集中在控制性能评估、控制优化和先进的患者建模上。在 Simulink/MATLAB 环境中进行了性能分析和实现。还讨论了基于 GOA 技术的 1 型糖尿病系统的性能分析,并优化了控制器参数,以提高控制性能。仿真结果表明,与其他传统控制器(如 PSO-PID 和 EHO-PID)相比,所提出算法的性能得到了显著提高,取得了更好的结果。